GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Apr 2021 03:00 PM
RNS
EU approves GSK's JEMPERLI (dostarlimab-gxly)
23 Apr 2021 07:00 AM
RNS
FDA approves GSK's JEMPERLI (dostarlimab-gxly)
16 Apr 2021 04:00 PM
RNS
Director/PDMR Shareholding
15 Apr 2021 03:21 PM
RNS
Director/PDMR Shareholding
15 Apr 2021 10:17 AM
RNS
Director/PDMR Shareholding
14 Apr 2021 02:14 PM
RNS
Director/PDMR Shareholding
14 Apr 2021 11:58 AM
RNS
Director/PDMR Shareholding
12 Apr 2021 05:32 PM
RNS
Director/PDMR Shareholding
12 Apr 2021 09:48 AM
RNS
Director/PDMR Shareholding
09 Apr 2021 05:34 PM
RNS
Director/PDMR Shareholding
09 Apr 2021 01:35 PM
RNS
Director/PDMR Shareholding
06 Apr 2021 02:30 PM
RNS
Directorate Change
01 Apr 2021 03:36 PM
RNS
Total Voting Rights
30 Mar 2021 04:21 PM
RNS
Publication of 2021 AGM Notice
30 Mar 2021 11:30 AM
RNS
GSK respiratory product sales reporting changes
24 Mar 2021 12:30 PM
RNS
Moncef Slaoui Departs Galvani Bioelectronics
23 Mar 2021 04:31 PM
RNS
Director/PDMR Shareholding
17 Mar 2021 06:24 PM
RNS
Chair of Audit & Risk Committee
16 Mar 2021 11:08 AM
RNS
Medicago and GSK start Phase 3 trial
15 Mar 2021 05:27 PM
RNS
Director/PDMR Shareholding
15 Mar 2021 07:00 AM
RNS
Annual Report 2020 on Form 20-F
11 Mar 2021 02:25 PM
RNS
Director/PDMR Shareholding
11 Mar 2021 07:00 AM
RNS
GSK and Vir share positive VIR-7831 data in COVID
10 Mar 2021 01:23 PM
RNS
Director/PDMR Shareholding
09 Mar 2021 01:43 PM
RNS
Annual Financial Report
02 Mar 2021 03:48 PM
RNS
Director/PDMR Shareholding
01 Mar 2021 10:55 AM
RNS
Total Voting Rights
25 Feb 2021 12:00 PM
RNS
GSK announces otilimab data for treatment of COVID
24 Feb 2021 01:59 PM
RNS
Director/PDMR Shareholding
24 Feb 2021 12:13 PM
RNS
Holding(s) in Company
23 Feb 2021 09:03 AM
RNS
Director/PDMR Shareholding
22 Feb 2021 04:39 PM
RNS
Director/PDMR Shareholding
22 Feb 2021 10:40 AM
RNS
Sanofi and GSK initiate new Phase 2 study
19 Feb 2021 12:52 PM
RNS
Director/PDMR Shareholding
19 Feb 2021 12:31 PM
RNS
Director/PDMR Shareholding
19 Feb 2021 10:32 AM
RNS
Director/PDMR Shareholding
18 Feb 2021 09:59 AM
RNS
Director/PDMR Shareholding
17 Feb 2021 12:00 PM
RNS
GSK/Vir collaborate on antibodies for influenza
17 Feb 2021 09:00 AM
RNS
Director/PDMR Shareholding
15 Feb 2021 10:09 AM
RNS
Director/PDMR Shareholding
15 Feb 2021 09:15 AM
RNS
Director/PDMR Shareholding
12 Feb 2021 04:26 PM
RNS
Director/PDMR Shareholding
12 Feb 2021 04:23 PM
RNS
Director/PDMR Shareholding
12 Feb 2021 04:20 PM
RNS
Director/PDMR Shareholding
10 Feb 2021 05:05 PM
RNS
Director/PDMR Shareholding
10 Feb 2021 04:54 PM
RNS
Director/PDMR Shareholding
04 Feb 2021 11:15 AM
RNS
Director/PDMR Shareholding
03 Feb 2021 12:00 PM
RNS
Final Results
03 Feb 2021 07:00 AM
RNS
GSK/CureVac partner on new mRNA Covid-19 vaccines
01 Feb 2021 02:04 PM
RNS
Total Voting Rights

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings